See All Clinical Studies

Clinical and Molecular Investigations Into Ciliopathies

This study will evaluate patients’ ciliopathies. People with ciliopathies develop fibrocystic disease of the kidneys and liver, retinal degeneration, obesity, structural and functional defects of the central nervous system and the eyes, abnormal bone growth, abnormal sidedness of internal organs and polydactyly. The goal of the study is to better understand the medical complications of these disorders and identify characteristics that can help in the design of new treatments.

Participant information:

Inclusion criteria:

  • This protocol will enroll children and adults who carry a clinical diagnosis of ARPKD, CHF, JSRD, BBS, OFD or AS and who has either PKD/NP spectrum of changes in the kidneys or CHF/Caroli’s syndrome of the liver. This might rarely include adults who are unable to give informed consent.Among patients who have received a kidney or liver allograft, those with stable graft function and without severe transplant-related complications are eligible for enrollment. Patients and their parents/legal guardians must be willing to come to the NIH Clinical Center for admission annually.

Exclusion criteria:

  • Infants under 6 months of age.
  • Medically fragile patients who require frequent hospitalizations due to complications of end-stage renal disease (uncontrolled hypertension, severe electrolyte imbalances) or hepatic disease (current variceal bleeding, overt encephalopathy, intractable recurrent cholangitis).

Contact information:

For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)
800.411.1222 ext. TTY8664111010
prpl@mail.cc.nih.gov